Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Novo Nordisk Is Ending Insulin Product Sales In The U S Three Senators Are Not Happy is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Novo Nordisk Shares Jump After CEO Predicts Wegovy Recovery as Compounded Drugs Exit U.S. Market
Shares of Novo Nordisk climbed nearly 7% on Wednesday after the company said sales of its obesity drug Wegovy are expected to rebound in the second half of the year as compounded copycat drugs exit ... Read More
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast. Read More
Novo Nordisk's Stellar Wegovy-Fuelled Run of Hiking Sales Guidance Could Be Ending
LONDON (Reuters) - Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales ... the week ending April 11. Novo and its rivals also face the threat ... Read More
Texas Health Resources sues over insulin prices, mirroring hundreds of other lawsuits
At the end of March, Texas Health Resources filed a lawsuit against pharmaceutical companies Eli Lilly, Novo Nordisk ... the state’s consumer protection laws by spiking insulin prices. Read More
Novo Nordisk clarifies Mixtard insulin vials will still be available, as penfills get phased out
Novo Nordisk’s insulin brand ... who could afford the product could speak to their doctors and shift to a similar product, while those who could afford the vials would not be affected, he ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus